Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / XGN - Exagen outlines $65M-$70M 2025 revenue target and positive adjusted EBITDA trajectory while advancing biomarker pipeline

XGN - Exagen outlines $65M-$70M 2025 revenue target and positive adjusted EBITDA trajectory while advancing biomarker pipeline

Exagen Inc.

2025-07-29 15:10:18 ET

More on Exagen

For further details see:

Exagen outlines $65M–$70M 2025 revenue target and positive adjusted EBITDA trajectory while advancing biomarker pipeline

Stock Information
Company Name: Exagen Inc.
Stock Symbol: XGN
Market: NASDAQ
Website: exagen.com
Menu
XGN XGN Quote XGN Short XGN News XGN Articles XGN Message Board
Get XGN Alerts

News, Short Squeeze, Breakout and More Instantly...